VeonGen Therapeutics
Pre-clinicalAt VeonGen Therapeutics (formerly ViGeneron), we are dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need.
Founded
2020
Focus
RNA & Gene TherapyViral Technology
About
At VeonGen Therapeutics (formerly ViGeneron), we are dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need.
Company Info
TypePrivate
Founded2020
LocationMunich, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile